Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07154680Completed

Ophthalmic Diseases and AI: an RCT Study

Role: lead

NCT06909604Not ApplicableRecruiting

Al18F-HER2-BCH PET in Breast Patients Treated With Neoadjuvant Therapy

Role: collaborator

NCT04547309Not ApplicableRecruiting

Research for the Molecular Imaging of the HER2 Targeting Tracer

Role: collaborator

NCT06457269Not ApplicableCompleted

Evaluating the Potential of Large Language Models for Respiratory Disease Consultations

Role: lead

NCT06627985Not Yet Recruiting

Multi-Disciplinary Treatment on the Anthropomorphism of Large Language Models

Role: lead

All 5 trials loaded